ID28953A - 4-(aminometil)-piperidina benzamida untuk mengobati gangguan gastrointestinal - Google Patents

4-(aminometil)-piperidina benzamida untuk mengobati gangguan gastrointestinal

Info

Publication number
ID28953A
ID28953A IDW00200101336A ID20011336A ID28953A ID 28953 A ID28953 A ID 28953A ID W00200101336 A IDW00200101336 A ID W00200101336A ID 20011336 A ID20011336 A ID 20011336A ID 28953 A ID28953 A ID 28953A
Authority
ID
Indonesia
Prior art keywords
aminometyl
benzamide
piperidine
gastrointestinal disorders
treat gastrointestinal
Prior art date
Application number
IDW00200101336A
Other languages
English (en)
Indonesian (id)
Inventor
J P R M A Bosmans
Ann L G Meulemans
M A J De Cleyn
H J M Gijsen
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of ID28953A publication Critical patent/ID28953A/id

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
IDW00200101336A 1998-12-22 1999-12-14 4-(aminometil)-piperidina benzamida untuk mengobati gangguan gastrointestinal ID28953A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP98204411 1998-12-22

Publications (1)

Publication Number Publication Date
ID28953A true ID28953A (id) 2001-07-19

Family

ID=8234539

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW00200101336A ID28953A (id) 1998-12-22 1999-12-14 4-(aminometil)-piperidina benzamida untuk mengobati gangguan gastrointestinal

Country Status (34)

Country Link
US (2) US6544997B1 (de)
EP (1) EP1140915B1 (de)
JP (1) JP4615725B2 (de)
KR (1) KR100633680B1 (de)
CN (1) CN1150190C (de)
AR (1) AR024240A1 (de)
AT (1) ATE297917T1 (de)
AU (1) AU770397B2 (de)
BG (1) BG64953B1 (de)
BR (1) BR9916491A (de)
CA (1) CA2355857C (de)
CZ (1) CZ300851B6 (de)
DE (1) DE69925865T2 (de)
DK (1) DK1140915T3 (de)
EA (1) EA003608B1 (de)
EE (1) EE200100335A (de)
ES (1) ES2245131T3 (de)
HK (1) HK1039114B (de)
HR (1) HRP20010445A2 (de)
HU (1) HUP0104838A3 (de)
ID (1) ID28953A (de)
IL (1) IL143858A (de)
MY (1) MY121852A (de)
NO (1) NO321324B1 (de)
NZ (1) NZ512871A (de)
PL (1) PL197409B1 (de)
PT (1) PT1140915E (de)
SI (1) SI1140915T1 (de)
SK (1) SK285829B6 (de)
TR (1) TR200101962T2 (de)
TW (1) TW570920B (de)
UA (1) UA71591C2 (de)
WO (1) WO2000037461A1 (de)
ZA (1) ZA200105135B (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7485665B2 (en) * 2002-09-12 2009-02-03 Nagase Chemtex Corporation Medicinal composition
ATE486865T1 (de) 2003-06-19 2010-11-15 Janssen Pharmaceutica Nv Hydroxycarbonylphenyl substituierte 4- (aminomethyl)-piperidinbenzamide als 5ht4- antagonisten
JP4916878B2 (ja) * 2003-06-19 2012-04-18 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ ５ｈｔ４−拮抗薬としてのアミノスルホニル置換４−（アミノメチル）−ピペリジンベンズアミド
CA2528642C (en) 2003-06-19 2011-12-13 Janssen Pharmaceutica N.V. Heterocyclic substituted 4-(aminomethyl)-piperidine benzamides as 5ht4-antagonists
KR20060022702A (ko) 2003-06-19 2006-03-10 얀센 파마슈티카 엔.브이. 5ｈｔ4-길항성 4-(아미노메틸)-피페리딘벤즈아미드
JO2478B1 (en) 2003-06-19 2009-01-20 جانسين فارماسوتيكا ان. في. (Aminomethyl) -biperidine benzamides as 5 HT4 antagonists
CA2537127C (en) 2003-09-03 2011-04-05 Pfizer Inc. Benzimidazolone compounds having 5-ht4 receptor agonistic activity
DE602004026095D1 (de) * 2003-11-24 2010-04-29 Pfizer Chinoloncarbonsäureverbindungen mit 5-ht4-rezeptoragonistischer wirkung
TW200533348A (en) * 2004-02-18 2005-10-16 Theravance Inc Indazole-carboxamide compounds as 5-ht4 receptor agonists
US8309575B2 (en) 2004-04-07 2012-11-13 Theravance, Inc. Quinolinone-carboxamide compounds as 5-HT4 receptor agonists
US7728006B2 (en) * 2004-04-07 2010-06-01 Theravance, Inc. Quinolinone-carboxamide compounds as 5-HT4 receptor agonists
TWI351282B (en) 2004-04-07 2011-11-01 Theravance Inc Quinolinone-carboxamide compounds as 5-ht4 recepto
AU2005254800B2 (en) 2004-06-15 2010-12-09 Pfizer Inc. Benzimidazolone carboxylic acid derivatives
US20060035890A1 (en) * 2004-08-10 2006-02-16 Amit Banerjee Compounds and methods for the treatment of ubiquitin conjugating disorders
JP5042028B2 (ja) * 2004-11-05 2012-10-03 セラヴァンス， インコーポレーテッド キノリノン−カルボキサミド化合物
DE602005016446D1 (de) * 2004-11-05 2009-10-15 Theravance Inc 5-HT4-Rezeptoragonistenverbindungen
KR20070091665A (ko) * 2004-12-22 2007-09-11 세라밴스 인코포레이티드 인다졸－카르복사미드 화합물
WO2006094063A1 (en) * 2005-03-02 2006-09-08 Theravance, Inc. Quinolinone compounds as 5-ht4 receptor agonists
US9101160B2 (en) 2005-11-23 2015-08-11 The Coca-Cola Company Condiments with high-potency sweetener
US8017168B2 (en) 2006-11-02 2011-09-13 The Coca-Cola Company High-potency sweetener composition with rubisco protein, rubiscolin, rubiscolin derivatives, ace inhibitory peptides, and combinations thereof, and compositions sweetened therewith
US8377968B2 (en) * 2008-06-02 2013-02-19 Zalicus Pharmaceuticals, Ltd. N-piperidinyl acetamide derivatives as calcium channel blockers
WO2014134306A1 (en) 2013-03-01 2014-09-04 Zalicus Pharmaceuticals, Ltd. Heterocyclic inhibitors of the sodium channel
US20180305334A1 (en) * 2015-10-14 2018-10-25 Aquinnah Pharmaceuticals, Inc. Compounds, compositions and methods of use against stress granules
EP3996746A4 (de) 2019-07-11 2023-08-23 Praxis Precision Medicines, Inc. Formulierungen von calciumkanalmodulatoren vom t-typ und verwendungsverfahren dafür

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ225152A (en) * 1987-07-17 1990-04-26 Janssen Pharmaceutica Nv Heterocyclically substituted piperidinyl benzamides as pharmaceuticals
CA1317940C (en) * 1987-09-25 1993-05-18 Georges H. P. Van Daele Substituted n-(1-alkyl-3-hydroxy-4-piperidinyl)benzamides
US5374637A (en) * 1989-03-22 1994-12-20 Janssen Pharmaceutica N.V. N-(3-hydroxy-4-piperidinyl)(dihydrobenzofuran, dihydro-2H-benzopyran or dihydrobenzodioxin)carboxamide derivatives
NZ243993A (en) 1991-08-20 1994-10-26 Smithkline Beecham Plc Pharmaceutical compositions having 5-ht4 receptor antagonist activity and selected compounds having such activity
US5580885A (en) * 1991-09-12 1996-12-03 Smithkline Beecham P.L.C. 5-HT4 receptor antagonists
US6323212B1 (en) * 1992-01-23 2001-11-27 Toray Industries, Inc. Morphinan derivative and its pharmaceutical applications
AU667874B2 (en) * 1992-02-06 1996-04-18 Smithkline Beecham Plc Benzopyran, benzothiopyran and benzofuran derivatives as 5-HT4 antagonists
GB9219163D0 (en) 1992-09-10 1992-10-28 Smithkline Beecham Plc Pharmaceuticals
MX9306311A (es) 1992-10-13 1994-04-29 Smithkline Beecham Plc Compuestos antagonistas del receptor de 5-ht4, procedimiento para su preparacion y composiciones farmaceuticas que los contienen
EP0664805A1 (de) 1992-10-13 1995-08-02 Smithkline Beecham Plc Heterozyklische karbonsäure-estern oder amide verwendbar als 5-ht4 rezeptor antagonisten
US5705498A (en) 1992-11-05 1998-01-06 Smithkline Beecham Plc. Piperidine derivatives as 5-HT4 receptor antagonists
GB9301660D0 (en) 1993-01-28 1993-03-17 Smithkline Beecham Plc Pharmaceuticals
GB9312348D0 (en) 1993-06-16 1993-07-28 Smithkline Beecham Plc Pharmaceuticals
ES2103675B1 (es) * 1995-01-10 1998-07-01 Almirall Lab Nuevas piperidinas sustituidas.
IT1275903B1 (it) 1995-03-14 1997-10-24 Boehringer Ingelheim Italia Esteri e ammidi della 1,4-piperidina disostituita
GB9507882D0 (en) * 1995-04-18 1995-05-31 Pharmacia Spa Substituted dihydrobenzofuran derivatives as 5-ht4 agonists
ES2208870T3 (es) * 1996-02-15 2004-06-16 Janssen Pharmaceutica N.V. Uso de antagonistas del receptor 5ht4 para resolver los efectos gastrointestinales de los inhibidores de la reabsorcion de serotonina.
TW445263B (en) 1996-02-29 2001-07-11 Janssen Pharmaceutica Nv Novel esters of 1,4-disubstituted piperidine derivatives
TW402591B (en) * 1997-07-11 2000-08-21 Janssen Pharmaceutica Nv Monocyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives
CA2340952C (en) * 1998-09-10 2009-12-08 F. Hoffmann-La Roche Ag Dihydrobenzodioxine carboxamide and ketone derivatives as 5-ht4 receptor antagonists
DE10217868A1 (de) * 2002-04-22 2003-10-30 Jomed N V Ballon-Katheter

Also Published As

Publication number Publication date
CN1150190C (zh) 2004-05-19
NO20012858L (no) 2001-06-08
EA200100710A1 (ru) 2001-12-24
AU2432800A (en) 2000-07-12
DE69925865T2 (de) 2006-05-11
KR100633680B1 (ko) 2006-10-11
NZ512871A (en) 2002-11-26
ES2245131T3 (es) 2005-12-16
HUP0104838A3 (en) 2003-05-28
CA2355857C (en) 2008-10-28
US7205410B2 (en) 2007-04-17
SK8592001A3 (en) 2002-02-05
PL348417A1 (en) 2002-05-20
HRP20010445A2 (en) 2002-06-30
EP1140915A1 (de) 2001-10-10
TR200101962T2 (tr) 2002-04-22
BG64953B1 (bg) 2006-10-31
JP4615725B2 (ja) 2011-01-19
HK1039114B (en) 2005-08-19
IL143858A0 (en) 2002-04-21
SI1140915T1 (sl) 2005-12-31
CZ20012117A3 (cs) 2001-10-17
ATE297917T1 (de) 2005-07-15
DE69925865D1 (de) 2005-07-21
TW570920B (en) 2004-01-11
EA003608B1 (ru) 2003-06-26
SK285829B6 (sk) 2007-09-06
BG105571A (en) 2002-01-31
AU770397B2 (en) 2004-02-19
US20030181456A1 (en) 2003-09-25
EE200100335A (et) 2002-08-15
EP1140915B1 (de) 2005-06-15
DK1140915T3 (da) 2005-10-10
AR024240A1 (es) 2002-09-25
KR20010080293A (ko) 2001-08-22
NO20012858D0 (no) 2001-06-08
ZA200105135B (en) 2002-06-21
MY121852A (en) 2006-02-28
CA2355857A1 (en) 2000-06-29
JP2002533337A (ja) 2002-10-08
WO2000037461A1 (en) 2000-06-29
PT1140915E (pt) 2005-11-30
PL197409B1 (pl) 2008-03-31
BR9916491A (pt) 2001-09-04
IL143858A (en) 2005-03-20
US6544997B1 (en) 2003-04-08
UA71591C2 (en) 2004-12-15
HK1039114A1 (en) 2002-04-12
HUP0104838A2 (hu) 2002-07-29
NO321324B1 (no) 2006-04-24
CZ300851B6 (cs) 2009-08-26
CN1331690A (zh) 2002-01-16

Similar Documents

Publication Publication Date Title
ATE297917T1 (de) 4-(aminomethyl)-piperidinbenzamide zur behandlung von gastrointestinalen störungen
ID24481A (id) Gastrokinetik monosiklik benzamida dari derivat-3-atau-tersubstitusi 4-(aminometil)-piperidin
DE60118908D1 (de) Behandlung von mineralischen stoffen
ATE411332T1 (de) 3'-prodrugs von 2'-deoxy-beta-l-nukleosiden
NO20014047L (no) Monoamin reopptaksinhibitorer for behandling av CNS forstyrrelser
DK1165510T3 (da) 1-arensulfonyl-2-aryl-pyrrolidin- og -piperidinderivater til behandling af CNS-lidelser
DE59912795D1 (de) Substituierte Benzamide und ihre Verwendung als Immunmodulatoren
PL357674A1 (pl) Kompozycje i sposoby leczenia zaburzeń związanychz hiperlipidemią
EP1379236A4 (de) Behandlung von tics, tremor und verwandten störungen
ID27214A (id) Triazolopiridina untuk pengobatan gangguan trombosis
EP1494696A4 (de) Behandlung von lungenerkrankungen
DE60107074D1 (de) Kristallin form ii von cabergolin
NO20006547D0 (no) Salter av paroxetine
NO20032156D0 (no) Behandling av angstforstyrrelser
DE60019145D1 (de) Verwendung von carbonylaminoderivaten gegen zentralnervensystem-störungen
NO20003960D0 (no) Salter av paroksetin
DE69908951D1 (de) Kristallformen von osanetant
DE60117122D1 (de) Verwendung von mirtazapin zur behandlung von schlafstörungen
NO20010390D0 (no) Behandling av angstsykdommer
ATE256662T1 (de) Amorphe modifikation von torasemid
NO20014953L (no) Anvendelse av osanetant for fremstilling av medikamenter anvendt for å behandle sinnsstemningslidelser
ATE221882T1 (de) Neue substituierte n-methyl-n-(4-(4-(1h- benzimidazol-2-yl-amino)-piperidin-1-yl)- 2(aryl)butyl)benzamide zur behandlung von allergischen krankheiten
NO993372D0 (no) Substituerte 4-(6-fluor-(1H)-indol-3-yl)-1,2,3,6-tetrahydropyridin for behandling av CNS-forstyrrelser
DE60102471D1 (de) Indolderivate zur verwendung in der behandlung von zns-störungen
DE60336549D1 (de) Hepatoprotektor aktivität von 2'-p-hydroxybenzoylmussaenosidsäure